The ribosome is a major target for clinically used antibiotics, but multidrug resistant pathogenic bacteria are making our current arsenal of antimicrobials obsolete. Here we present cryo-electron-microscopy structures of 17 distinct compounds from six different antibiotic classes bound to the bacterial ribosome at resolutions ranging from 1.6 to 2.2 Å. The improved resolution enables a precise description of antibiotic-ribosome interactions, encompassing solvent networks that mediate multiple additional interactions between the drugs and their target. Our results reveal a high structural conservation in the binding mode between antibiotics with the same scaffold, including ordered water molecules. Water molecules are visualized within the antibiotic binding sites that are preordered, become ordered in the presence of the drug and that are physically displaced on drug binding. Insight into RNA-ligand interactions will facilitate development of new antimicrobial agents, as well as other RNA-targeting therapies.

Central European Institute of Technology Masaryk University Brno Czech Republic

Dubochet Center for Imaging at EPFL UNIL Batiment Cubotron Lausanne Switzerland

Institute for Biochemistry and Molecular Biology University of Hamburg Hamburg Germany

Theoretical and Computational Biophysics Department Max Planck Institute for Multidisciplinary Sciences Göttingen Germany

Zobrazit více v PubMed

Yonath A. Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. Annu. Rev. Biochem. 2005;74:649–679. doi: 10.1146/annurev.biochem.74.082803.133130. PubMed DOI

Sohmen D, Harms JM, Schlunzen F, Wilson DN. SnapShot: antibiotic inhibition of protein synthesis I. Cell. 2009;138:1248 e1241. doi: 10.1016/j.cell.2009.08.001. PubMed DOI

Wilson DN. The A-Z of bacterial translation inhibitors. Crit. Rev. Biochem. Mol. Biol. 2009;44:393–433. doi: 10.3109/10409230903307311. PubMed DOI

Wilson DN. Ribosome-targeting antibiotics and bacterial resistance mechanisms. Nat. Rev. Microbiol. 2014;12:35–48. doi: 10.1038/nrmicro3155. PubMed DOI

Polikanov YS, Aleksashin NA, Beckert B, Wilson DN. The mechanisms of action of ribosome-targeting peptide antibiotics. Front. Mol. Biosci. 2018;5:48. doi: 10.3389/fmolb.2018.00048. PubMed DOI PMC

Lin J, Zhou D, Steitz TA, Polikanov YS, Gagnon MG. Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design. Annu. Rev. Biochem. 2018;87:451–478. doi: 10.1146/annurev-biochem-062917-011942. PubMed DOI PMC

Petrychenko V, et al. Structural mechanism of GTPase-powered ribosome-tRNA movement. Nat. Commun. 2021;12:5933. doi: 10.1038/s41467-021-26133-x. PubMed DOI PMC

Crowe-McAuliffe C, et al. Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics. Nat. Commun. 2022;13:1860. doi: 10.1038/s41467-022-29274-9. PubMed DOI PMC

Morgan, C. E., Zhang, Z., Bonomo, R. A. & Yu, E. W. An analysis of the novel fluorocycline TP-6076 bound to both the ribosome and multidrug efflux pump AdeJ from Acinetobacter baumannii. mBio13, e0373221 (2022). PubMed PMC

Tsai K, et al. Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics. Nat. Struct. Mol. Biol. 2022;29:162–171. doi: 10.1038/s41594-022-00723-9. PubMed DOI PMC

Itoh, Y. et al. Structure of the mitoribosomal small subunit with streptomycin reveals Fe-S clusters and physiological molecules. eLife11, e77460 (2022). PubMed PMC

Watson, Z. L. et al. Structure of the bacterial ribosome at 2 A resolution. eLife9, e60482 (2020). PubMed PMC

Wilson DN, Harms JM, Nierhaus KH, Schlünzen F, Fucini P. Species-specific antibiotic-ribosome interactions: Implications for drug development. Biol. Chem. 2005;386:1239–1252. doi: 10.1515/BC.2005.141. PubMed DOI

Wilson DN. On the specificity of antibiotics targeting the large ribosomal subunit. Ann. NY Acad. Sci. 2011;1241:1–16. doi: 10.1111/j.1749-6632.2011.06192.x. PubMed DOI

Ladbury JE. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem. Biol. 1996;3:973–980. doi: 10.1016/S1074-5521(96)90164-7. PubMed DOI

Krimmer SG, Betz M, Heine A, Klebe G. Methyl, ethyl, propyl, butyl: futile but not for water, as the correlation of structure and thermodynamic signature shows in a congeneric series of thermolysin inhibitors. Chem. Med. Chem. 2014;9:833–846. doi: 10.1002/cmdc.201400013. PubMed DOI

Darby JF, et al. Water networks can determine the affinity of ligand binding to proteins. J. Am. Chem. Soc. 2019;141:15818–15826. doi: 10.1021/jacs.9b06275. PubMed DOI

Matricon P, et al. Ligand design by targeting a binding site water. Chem. Sci. 2020;12:960–968. doi: 10.1039/D0SC04938G. PubMed DOI PMC

Samways ML, Taylor RD, Bruce Macdonald HE, Essex JW. Water molecules at protein-drug interfaces: computational prediction and analysis methods. Chem. Soc. Rev. 2021;50:9104–9120. doi: 10.1039/D0CS00151A. PubMed DOI

Wei W, Luo J, Waldispuhl J, Moitessier N. Predicting positions of bridging water molecules in nucleic acid-ligand complexes. J. Chem. Inf. Model. 2019;59:2941–2951. doi: 10.1021/acs.jcim.9b00163. PubMed DOI

Svetlov, M. S. et al. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Nat. Chem. Biol. 17, 412–420 (2021). PubMed PMC

Warner KD, Hajdin CE, Weeks KM. Principles for targeting RNA with drug-like small molecules. Nat. Rev. Drug Discov. 2018;17:547–558. doi: 10.1038/nrd.2018.93. PubMed DOI PMC

Falese JP, Donlic A, Hargrove AE. Targeting RNA with small molecules: from fundamental principles towards the clinic. Chem. Soc. Rev. 2021;50:2224–2243. doi: 10.1039/D0CS01261K. PubMed DOI PMC

Childs-Disney, J. L. et al. Targeting RNA structures with small molecules. Nat. Rev. Drug Discov.21, 736–762 (2022). PubMed PMC

Kimanius D, Dong L, Sharov G, Nakane T, Scheres SHW. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem J. 2021;478:4169–4185. doi: 10.1042/BCJ20210708. PubMed DOI PMC

Brodersen DE, et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell. 2000;103:1143–1154. doi: 10.1016/S0092-8674(00)00216-6. PubMed DOI

Pioletti M, et al. Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J. 2001;20:1829–1839. doi: 10.1093/emboj/20.8.1829. PubMed DOI PMC

Borovinskaya MA, et al. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat. Struct. Mol. Biol. 2007;14:727–732. doi: 10.1038/nsmb1271. PubMed DOI

Matt T, et al. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc. Natl Acad. Sci. USA. 2012;109:10984–10989. doi: 10.1073/pnas.1204073109. PubMed DOI PMC

Schluenzen F, et al. The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation. Nat. Struct. Mol. Biol. 2006;13:871–878. doi: 10.1038/nsmb1145. PubMed DOI

Zhang Z, Morgan CE, Bonomo RA, Yu EW. Cryo-EM determination of eravacycline-bound structures of the ribosome and the multidrug efflux pump AdeJ of Acinetobacter baumannii. mBio. 2021;12:e0103121. doi: 10.1128/mBio.01031-21. PubMed DOI PMC

Stanley RE, Blaha G, Grodzicki RL, Strickler MD, Steitz TA. The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nat. Struct. Mol. Biol. 2010;17:289–293. doi: 10.1038/nsmb.1755. PubMed DOI PMC

Zhang L, et al. The structural basis for inhibition of ribosomal translocation by viomycin. Proc. Natl Acad. Sci. USA. 2020;117:10271–10277. doi: 10.1073/pnas.2002888117. PubMed DOI PMC

Nguyen F, et al. Tetracycline antibiotics and resistance mechanisms. Biol. Chem. 2014;395:559–575. doi: 10.1515/hsz-2013-0292. PubMed DOI

Natchiar SK, Myasnikov AG, Kratzat H, Hazemann I, Klaholz BP. Visualization of chemical modifications in the human 80S ribosome structure. Nature. 2017;551:472–477. doi: 10.1038/nature24482. PubMed DOI

Brodersen DE, Clemons WM, Jr., Carter AP, Wimberly BT, Ramakrishnan V. Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. J. Mol. Biol. 2002;316:725–768. doi: 10.1006/jmbi.2001.5359. PubMed DOI

Borovinskaya MA, Shoji S, Fredrick K, Cate JH. Structural basis for hygromycin B inhibition of protein biosynthesis. RNA. 2008;14:1590–1599. doi: 10.1261/rna.1076908. PubMed DOI PMC

Ganguly AK. Ziracin, a novel oligosaccharide antibiotic. J. Antibiot. 2000;53:1038–1044. doi: 10.7164/antibiotics.53.1038. PubMed DOI

Adrian PV, et al. Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrob. Agents Chemother. 2000;44:3101–3106. doi: 10.1128/AAC.44.11.3101-3106.2000. PubMed DOI PMC

Adrian PV, et al. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob. Agents Chemother. 2000;44:732–738. doi: 10.1128/AAC.44.3.732-738.2000. PubMed DOI PMC

Belova L, Tenson T, Xiong LQ, McNicholas PM, Mankin AS. A novel site of antibiotic action in the ribosome: Interaction of evernimicin with the large ribosomal subunit. Proc. Natl Acad. Sci. USA. 2001;98:3726–3731. doi: 10.1073/pnas.071527498. PubMed DOI PMC

Kofoed CB, Vester B. Interaction of avilamycin with ribosomes and resistance caused by mutations in 23S rRNA. Antimicrob. Agents Chemother. 2002;46:3339–3342. doi: 10.1128/AAC.46.11.3339-3342.2002. PubMed DOI PMC

Arenz S, et al. Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome. Proc. Natl Acad. Sci. USA. 2016;113:7527–7532. doi: 10.1073/pnas.1604790113. PubMed DOI PMC

Krupkin M, et al. Avilamycin and evernimicin induce structural changes in rProteins uL16 and CTC that enhance the inhibition of A-site tRNA binding. Proc. Natl Acad. Sci. USA. 2016;113:E6796–E6805. doi: 10.1073/pnas.1614297113. PubMed DOI PMC

Schwarz, S. et al. Lincosamides, streptogramins, phenicols, and pleuromutilins: mode of action and mechanisms of resistance. Cold Spring Harb. Persp. Med.6, a027037 (2016). PubMed PMC

Mitcheltree MJ, et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. Nature. 2021;599:507–512. doi: 10.1038/s41586-021-04045-6. PubMed DOI PMC

Koller TO, et al. Structural basis for HflXr-mediated antibiotic resistance in Listeria monocytogenes. Nucleic Acids Res. 2022;50:11285–11300. doi: 10.1093/nar/gkac934. PubMed DOI PMC

Novak R, Shlaes DM. The pleuromutilin antibiotics: a new class for human use. Curr. Opin. Investig. Drugs. 2010;11:182–191. PubMed

Gurel G, Blaha G, Moore PB, Steitz TA. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. J. Mol. Biol. 2009;389:146–156. doi: 10.1016/j.jmb.2009.04.005. PubMed DOI PMC

Schlunzen F, Pyetan E, Fucini P, Yonath A, Harms J. Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. Microbiol. 2004;54:1287–1294. doi: 10.1111/j.1365-2958.2004.04346.x. PubMed DOI

Davidovich C, et al. Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity. Proc. Natl Acad. Sci. USA. 2007;104:4291–4296. doi: 10.1073/pnas.0700041104. PubMed DOI PMC

Eyal Z, et al. Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus. Proc. Natl Acad. Sci. USA. 2015;112:E5805–E5814. doi: 10.1073/pnas.1517952112. PubMed DOI PMC

Eyal Z, et al. A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism. Sci. Rep. 2016;6:39004. doi: 10.1038/srep39004. PubMed DOI PMC

Bock LV, Grubmuller H. Effects of cryo-EM cooling on structural ensembles. Nat. Commun. 2022;13:1709. doi: 10.1038/s41467-022-29332-2. PubMed DOI PMC

Rundlet EJ, et al. Structural basis of early translocation events on the ribosome. Nature. 2021;595:741–745. doi: 10.1038/s41586-021-03713-x. PubMed DOI PMC

Blaha G, et al. Preparation of functional ribosomal complexes and the effect of buffer conditions on tRNA positions observed by cryoelectron microscopy. Methods Enzymol. 2000;317:292–309. doi: 10.1016/S0076-6879(00)17021-1. PubMed DOI

Mastronarde DN. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 2005;152:36–51. doi: 10.1016/j.jsb.2005.07.007. PubMed DOI

Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193. PubMed DOI PMC

Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216–221. doi: 10.1016/j.jsb.2015.08.008. PubMed DOI PMC

Wagner T, et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2019;2:218. doi: 10.1038/s42003-019-0437-z. PubMed DOI PMC

Bepler T, et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods. 2019;16:1153–1160. doi: 10.1038/s41592-019-0575-8. PubMed DOI PMC

Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012;180:519–530. doi: 10.1016/j.jsb.2012.09.006. PubMed DOI PMC

Zivanov J, Nakane T, Scheres SHW. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ. 2019;6:5–17. doi: 10.1107/S205225251801463X. PubMed DOI PMC

Goddard TD, et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 2018;27:14–25. doi: 10.1002/pro.3235. PubMed DOI PMC

Rosenthal P, Henderson R. Optimal determination of particle orientation, absolute hand, and control loss in single particle electron microscopy. J. Mol. Biol. 2003;333:721–745. doi: 10.1016/j.jmb.2003.07.013. PubMed DOI

Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. PubMed DOI

Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. PubMed DOI PMC

Yamashita K, Palmer CM, Burnley T, Murshudov GN. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. D. Struct. Biol. 2021;77:1282–1291. doi: 10.1107/S2059798321009475. PubMed DOI PMC

Rozov A, et al. Importance of potassium ions for ribosome structure and function revealed by long-wavelength X-ray diffraction. Nat. Commun. 2019;10:2519. doi: 10.1038/s41467-019-10409-4. PubMed DOI PMC

Schuttelkopf AW, van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D. Biol. Crystallogr. 2004;60:1355–1363. doi: 10.1107/S0907444904011679. PubMed DOI

Long F, et al. AceDRG: a stereochemical description generator for ligands. Acta Crystallogr. D. Struct. Biol. 2017;73:112–122. doi: 10.1107/S2059798317000067. PubMed DOI PMC

Moriarty NW, Grosse-Kunstleve RW, Adams PD. Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D. Biol. Crystallogr. 2009;65:1074–1080. doi: 10.1107/S0907444909029436. PubMed DOI PMC

Chen VB, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:12–21. doi: 10.1107/S0907444909042073. PubMed DOI PMC

Abraham MJ, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25. doi: 10.1016/j.softx.2015.06.001. DOI

Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 1990;8:52–56. doi: 10.1016/0263-7855(90)80070-V. PubMed DOI

Maier JA, et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255. PubMed DOI PMC

Izadi S, Anandakrishnan R, Onufriev AV. Building water models: a different approach. J. Phys. Chem. Lett. 2014;5:3863–3871. doi: 10.1021/jz501780a. PubMed DOI PMC

Joung IS, Cheatham TE., 3rd Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J. Phys. Chem. B. 2008;112:9020–9041. doi: 10.1021/jp8001614. PubMed DOI PMC

Grotz KK, Schwierz N. Magnesium force fields for OPC water with accurate solvation, ion-binding, and water-exchange properties: successful transfer from SPC/E. J. Chem. Phys. 2022;156:114501. doi: 10.1063/5.0087292. PubMed DOI

Aduri R, et al. AMBER force field parameters for the naturally occurring modified nucleosides in RNA. J. Chem. Theory Comput. 2007;3:1464–1475. doi: 10.1021/ct600329w. PubMed DOI

Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157–1174. doi: 10.1002/jcc.20035. PubMed DOI

Sousa da Silva AW, Vranken WF. ACPYPE—antechamber Python parser interface. BMC Res. Notes. 2012;5:367. doi: 10.1186/1756-0500-5-367. PubMed DOI PMC

Wang J, Wang W, Kollman PA, Case DA. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph Model. 2006;25:247–260. doi: 10.1016/j.jmgm.2005.12.005. PubMed DOI

Essmann U, et al. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577–8593. doi: 10.1063/1.470117. DOI

Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684–3690 (1984).

Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182–7190 (1981).

Hess B. P-LINCS: a parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 2008;4:116–122. doi: 10.1021/ct700200b. PubMed DOI

Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126:014101. doi: 10.1063/1.2408420. PubMed DOI

Schuwirth BS, et al. Structural analysis of kasugamycin inhibition of translation. Nat. Struct. Mol. Biol. 2006;13:879–886. doi: 10.1038/nsmb1150. PubMed DOI PMC

Carter AP, et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature. 2000;407:340–348. doi: 10.1038/35030019. PubMed DOI

Demirci H, et al. A structural basis for streptomycin-induced misreading of the genetic code. Nat. Commun. 2013;4:1355. doi: 10.1038/ncomms2346. PubMed DOI PMC

Khawaja A, et al. Distinct pre-initiation steps in human mitochondrial translation. Nat. Commun. 2020;11:2932. doi: 10.1038/s41467-020-16503-2. PubMed DOI PMC

Jenner L, et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc. Natl Acad. Sci. USA. 2013;110:3812–3816. doi: 10.1073/pnas.1216691110. PubMed DOI PMC

Cocozaki AI, et al. Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc. Natl Acad. Sci. USA. 2016;113:8188–8193. doi: 10.1073/pnas.1605127113. PubMed DOI PMC

Yang K, et al. Structural insights into species-specific features of the ribosome from the human pathogen Mycobacterium tuberculosis. Nucleic Acids Res. 2017;45:10884–10894. doi: 10.1093/nar/gkx785. PubMed DOI PMC

Schlünzen F, et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 2001;413:814–821. doi: 10.1038/35101544. PubMed DOI

Tu D, Blaha G, Moore P, Steitz T. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell. 2005;121:257–270. doi: 10.1016/j.cell.2005.02.005. PubMed DOI

Dunkle JA, Xiong L, Mankin AS, Cate JH. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc. Natl Acad. Sci. USA. 2010;107:17152–17157. doi: 10.1073/pnas.1007988107. PubMed DOI PMC

Matzov D, et al. Structural insights of lincosamides targeting the ribosome of Staphylococcus aureus. Nucleic Acids Res. 2017;45:10284–10292. doi: 10.1093/nar/gkx658. PubMed DOI PMC

Schedlbauer A, et al. Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome. Antimicrob. Agents Chemother. 2015;59:2849–2854. doi: 10.1128/AAC.04895-14. PubMed DOI PMC

Nicholson D, Edwards TA, O’Neill AJ, Ranson NA. Structure of the 70S ribosome from the human pathogen Acinetobacter baumannii in complex with clinically relevant antibiotics. Structure. 2020;28:1087–1100 e1083. doi: 10.1016/j.str.2020.08.004. PubMed DOI PMC